Esperion Therapeutics, Inc. (ESPR)
| Previous close | 4.0100 |
| Open | 3.9500 |
| Bid | 4.0300 x 900 |
| Ask | 4.0400 x 1200 |
| Day's range | 3.8500 - 4.1000 |
| 52-week range | 3.5800 - 39.4900 |
| Volume | |
| Avg. volume | 2,244,569 |
| Market cap | 247.558M |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -11.6890 |
| Earnings date | 21 Feb 2022 - 25 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.36 |
- GlobeNewswire
Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program Update
– Unprecedented CLEAR Outcomes Trial Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 85% MACE Accumulation in December – – Fourth-quarter 2021 U.S. Net Product Revenue Estimated Between $12.0 to $12.5 Million – – Company Reiterates Full-Year 2022 Operating Expense Guidance of $220 to $240 Million – ANN ARBOR, Mich., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced preliminary, unaudited fourth-quarter 2021 financial res
- GlobeNewswire
Esperion to Participate in Upcoming Virtual J.P. Morgan 40th Annual Healthcare Conference
ANN ARBOR, Mich., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming virtual J.P. Morgan 40th Annual Healthcare Conference on Thursday, January 13, 2022 at 10:30 a.m. Eastern Time. Event:J.P. Morgan 40th Annual Healthcare ConferenceDate:Thursday, January 13, 2022Format:Presentation and 1:1 MeetingsTime:10:30 a.m. ET Live audio webcasts of these events can be accessed on the investor re
- Simply Wall St.
What Type Of Shareholders Own The Most Number of Esperion Therapeutics, Inc. (NASDAQ:ESPR) Shares?
Every investor in Esperion Therapeutics, Inc. ( NASDAQ:ESPR ) should be aware of the most powerful shareholder groups...
